10170 CHURCH RANCH WAY, WESTMINSTER, CO
Director Resignation and Appointment at Oruka Therapeutics
Announces Positive Interim Phase 1 Results for ORKA-001
News, Material Contracts
Shareholder votes
Annual Report to Security Holders
Material Contracts
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement